Real‐world, open‐label study to evaluate the effectiveness of mirtazapine on sleep quality in outpatients with major depressive disorder
Real‐world, open‐label study to evaluate the effectiveness of mirtazapine on sleep quality in outpatients with major depressive disorder
复制标题
DOI：
10.1111/appy.12060
复制
发表时间：
2014-06
期刊：
影响因子：
--
通讯作者：
Dan Wang;Ze-xuan Li;Lingjiang Li;Wei Hao
中科院分区：
文献类型：
--
作者：
Dan Wang;Ze-xuan Li;Lingjiang Li;Wei Hao
这项研究的目的是评估米氮平对真实世界中患有严重抑郁障碍(MDD)的门诊患者的睡眠质量的影响。
The objective of this study was to evaluate the effect of mirtazapine on sleep quality in real‐world outpatients with major depressive disorder (MDD).